|Year : 2016 | Volume
| Issue : 1 | Page : 89-93
Association of ACE Gene I/D polymorphism with migraine in Kashmiri population
Irfan Yousuf Wani1, Saleem Sheikh1, Zafar Amin Shah2, Arshid A Pandith2, Mushtaq Wani1, Ravouf Asimi1, Maqbool Wani1, Shahnawaz Sheikh2, Iqra Mehraj1
1 Department of Neurology, Sher-i-Kashmir Institute of Medical Sciences Medical College, Soura, Srinagar, Jammu and Kashmir, India
2 Department of Immunology and Molecular Medicine, Sher-i-Kashmir Institute of Medical Sciences Medical College, Soura, Srinagar, Jammu and Kashmir, India
|Date of Submission||11-Mar-2015|
|Date of Decision||13-Apr-2015|
|Date of Acceptance||18-May-2015|
|Date of Web Publication||2-Feb-2016|
Irfan Yousuf Wani
Department of Neurology, Sher-i-Kashmir Institute of Medical Sciences Medical College, Soura, Srinagar - 190 011, Jammu and Kashmir
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Introduction: Migraine is a complex, recurrent headache disorder that is one of the most common complaints in neurology practice. The role of various genes in its pathogenesis is being studied. We did this study to see whether an association exists between ACE gene I/D polymorphism and migraine in our region. Materials and Methods: The study included 100 patients diagnosed with migraine and 121 healthy controls. The study subject were age and gender matched. The analysis was based on Polymerase Chain Reaction (PCR) and included following steps: DNA extraction from blood, PCR and Restriction Fragment Length Polymorphism (RFLP). Results: Out of 100 cases, 69 were females and 31 were males. Fifty-seven were having migraine without aura and 43 had migraine with aura. 45 of the cases had II polymorphism, 40 had ID polymorphism and 15 had DD polymorphism in ACE gene. Conclusion: We were not able to find a statistically significant association between ACE gene I/D polymorphism with migraine. The reason for difference in results between our study and other studies could be because of different ethnicity in study populations. So a continuous research is needed in this regard in order to find the genes and different polymorphism that increase the susceptibility of Kashmiri population to migraine.
Keywords: ACE gene, gene polymorphism, migraine
|How to cite this article:|
Wani IY, Sheikh S, Shah ZA, Pandith AA, Wani M, Asimi R, Wani M, Sheikh S, Mehraj I. Association of ACE Gene I/D polymorphism with migraine in Kashmiri population. Ann Indian Acad Neurol 2016;19:89-93
|How to cite this URL:|
Wani IY, Sheikh S, Shah ZA, Pandith AA, Wani M, Asimi R, Wani M, Sheikh S, Mehraj I. Association of ACE Gene I/D polymorphism with migraine in Kashmiri population. Ann Indian Acad Neurol [serial online] 2016 [cited 2019 Aug 19];19:89-93. Available from: http://www.annalsofian.org/text.asp?2016/19/1/89/167698
| Introduction|| |
Migraine headache is a complex, recurrent headache disorder that is one of the most common complaints in neurology practice.  There are two main types of migraine and they are migraine without aura and migraine with aura. Migraines without aura is the most common type, accounting for more than 80% of all migraines. Based on different studies, the overall prevalence of migraine among men and women in the US is estimated at 12%. ,, In Asia the sex-specific migraine prevalence has been reported as 11.3-14.4% in women and 3.6-6.7% in men. 
Much research has been done to unravel the pathogenesis of migraine and the role of genetics has always been emphasized. The genetic basis of migraine is likely to be complex and in some individuals an additive effect of more than one genetic source may come into play. Individuals prone to migraine have a genetic threshold that renders them susceptible to an acute migraine attack depending upon the balance between excitation and inhibition at various levels of the nervous system.
Many people have shown interest in ACE gene I/D polymorphism in order to determine its role in health and disease states including migraine. In humans, the gene encoding ACE is located on the long arm of chromosome 17 (17q23). The gene is 21 kilo bases (kb) long and comprises 26 exons and 25 introns. More than 160 ACE gene polymorphisms have been listed till date and the most extensively studied polymorphism involves the presence (insertion, I) or absence (deletion, D) of a 287-bp sequence of DNA in intron 16 of the gene giving rise to three possible genotypes: II, ID or DD. It has been found that the mean ACE activity levels is different depending upon the type of I/D genotype. It has been found that there is relative excesses of the II genotype and commensurate deficiencies of the DD genotype in athletes like swimmers, runners and mountain climbers. ACE gene I/D polymorphism has been associated with a number of diseases like hypertension, diabetic nephropathy and Alzheimer's disease. Previous studies have demonstrated different results regarding whether an association between the ACE polymorphisms and migraine exists. As a result, the importance of the ACE ID polymorphism is not clearly understood. So we undertook this case-control study to see whether an association exists between ACE gene polymorphism and migraine in patients attending Outpatient services at Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Soura a tertiary-care hospital in Jammu and Kashmir, a state in North India.
| Materials and Methods|| |
The study entitled "Association of ACE gene I/D polymorphism with migraine" was conducted in the Sher-I-Kashmir Institute of Medical sciences, Soura, Srinagar, in the Department of Neurology and Department of Immunology and Molecular Medicine over a period of 2 yrs from January 2013. Clearance from local SKIMS ethical committee was taken prior to start of study. The study included 100 patients diagnosed with migraine and 121 healthy controls. The study subject were age and gender matched. Migraine was diagnosed according to the criteria from the International Headache Society.  A detailed medical history was obtained from each patient, and all study participants underwent a physical examination. The migraine patients who had any cardiovascular or cerebrovascular disease or hypertension, and smoked were excluded from this study. All patients with migraine were unrelated. Control subjects, who had never experienced a migraine headache, and had no family history of migraine were selected from the outpatient-neurology clinic. The controls had no cardiovascular or cerebrovascular disease or hypertension and none smoked.
Blood samples were taken from both the groups and a written pre informed consent was obtained from all the cases and controls. Five milliliters of peripheral blood was obtained from each subject in ethylenediaminetetraacetic acid (EDTA) containing vials (200 μl of 0.5 M, pH = 8.0) and stored at −20 °C till use.
Deoxyribonucleic acid (DNA) extraction was performed according to the manufacturer's protocol for Qiagen DNA extraction kits (Qiagen, Hilden, NRW, Germany). DNA content was quantified by spectrophotometric absorption (Nanodrop Spectrophotometer, BioLab, Scoresby, VIC, Australia).
Polymerase chain reaction (PCR) was performed using an iCycler Thermal Cycler (Bio-Rad, Hercules, CA, USA).
Molecular detection of the ACE I/D polymorphism was performed by PCR amplification of intron 16. The template DNA (0.5-1.0 ug) was used in a PCR under stringent conditions to avoid the possibility of false positives for ACE genotyping. The reactions was be carried out with 10 pmol of each primer: Forward primer, 5΄-CTG GAG ACC ACT CCC ATC CTT TCT-3΄, and reverse primer, 5΄-GAT GTG GCC ATC TTC GTC AGA T-3΄, in a final volume of 25 μL containing 1.5 mM MgCl2, 25 mM KCl, 5 mM Tris-HCl (pH 8.4), 0.25 mM each of deoxyribonucleotide triphosphate (dNTP, Biotools, Spain) and 1 unit Taq polymerase (Biotools, Spain). Amplification was carried out in a DNA thermal cycler (Pamcycler thermocycler) for 30 cycles with denaturation extension at 72 o C for 2 min. The PCR products were separated on a 2% agorose gel and DNA were visualized by ethidium bromide staining. The PCR product is a 490-bp fragment in the presence of the insertion (I) allele. Thus, each DNA sample revealed one of three possible patterns after electrophoresis: A 490-bp band (genotype I/I), a 190-bp band (genotype D/D), or both 490-bp and 190-bp bands (genotype I/D).
Restriction fragments were visualized after ethidium bromide staining of the agarose gel with the use of an ultraviolet transilluminator.
| Results|| |
Out of 100 cases taken in this study, 57 were having migraine without aura and 43 had migraine with aura. Demographic features of the studied cases like age distribution, residence, marital status are given in [Table 1] below.
The main objective of this study was to know the association between ACE gene I/D polymorphism and migraine in the kashmiri populations. The results of this study are presented in [Table 2], [Table 3], [Table 4], [Table 5] and [Table 6].
|Table 2: Below shows the number of patients of migraine with and without aura in different age groups|
Click here to view
|Table 6: Assocition of ace i/d polymorphism in migraine without aura in relation to migraine cases|
Click here to view
On comparing cases of migraine with aura and migraine without aura, we were not able to find a statistically significant relation between the two with regards to ACE gene I/D polymorphism.
Direct visualization of ACE I/D PCR products, electrophoresed on 2% agarose gel, by ethidium bromide staining [Figure 1]. A 490 base pair ACE I allele and 190 base pair ACE D allele is seen. Results from 8 patients are shown.
II homozygote genotypes: Lane 6 and 8.
DD homozygote: Lanes 3, 5 and 7
ID heterozygotes: Lane: 1 and 2.
Control (D. H2O): 4
As is evident from the results, no association could be found between ACE I/D polymorphism and migraine in the studied group.
| Discussion|| |
As of now, the pathogenesis of migraine is not known completely. It was previously considered to be a vascular phenomenon that resulted from intracranial vasoconstriction followed by rebound vasodilation. Currently, however, the neurovascular theory describes migraine as primarily a neurogenic process with secondary changes in cerebral perfusion associated with a sterile neurogenic inflammation. Some authors have proposed a dopaminergic basis for migraine.  Another theory proposes that deficiency of magnesium in the brain triggers a chain of events, starting with platelet aggregation and glutamate release and finally resulting in the release of 5-hydroxytryptamine, which is a vasoconstrictor. In clinical studies, oral magnesium has shown benefit for preventive treatment and intravenous magnesium may be effective for acute treatment, particularly in certain subsets of migraine patients.  The serotonin receptor 5-hydroxytryptamine (5-HT) is believed to be the most important receptor in the headache pathway. Immunohistochemical studies have detected 5-hydroxytryptamine-1D (5-HT1D) receptors in trigeminal sensory neurons, including peripheral projections to the dura and within the trigeminal nucleus caudalis (TNC) and solitary tract, while 5-HT1B receptors are present on smooth muscle cells in meningeal vessels; however, both can be found in both tissues to some extent and even in coronary vessels. The importance of seratonin in migraine is also determined from the fact that 5HT1B/1D receptor agonists that is triptans are very effective in abolishing an episode of migraine headache.
Migraine has a strong genetic component. Approximately 70% of migraine patients have a first-degree relative with a history of migraine. The risk of migraine is increased four-fold in relatives of people who have migraine with aura.  Large national registry-based twin studies have confirmed a consistently higher concordance of migraine in monozygotic twins versus dizygotic twins. In one such study, using a polygenic multifactorial model, researchers estimated that inheritance accounts for 40-50% of an individual's susceptibility to migraine. 
Angiotensin I-converting enzyme (ACE) is a part of the kinin-kallikrein cascade. It metabolizes bradykinin, a strong vasodilator, forming the inactive metabolite bradykinin. In addition to a prominent role in blood pressure regulation through the kinin-kallikrein cascade, ACE is the main active product of the renin-angiotensin system (RAS), a dipeptidyl carboxypeptidase that converts the inactive decapeptide, angiotensin I to angiotensin II, an active octapeptide and potent vasoconstrictor (angiotensin II). RAS maintains the long-term regulation of blood pressure and blood volume in the body.  As the actual pathogenesis of migraine is still not known so it is difficult to summarise the role of ACE gene in migraine but its importance is established by the facts that ACE gene polymorphism affects the vascular reactivity through difference in serum ACE level and that ACE inhibitors have been successfully used for migraine prophylaxis. It was because of these effects of ACE that studies were done to look for an association between ACE gene polymorphism and migraine.
In the National Center for Biotechnology Information (NCBI) records, more than 160 ACE gene polymorphisms are listed, most of which are single nucleotide polymorphisms (SNPs). Only 34 of those polymorphisms are located in coding regions with 18 of them being missense mutations. It was Rigat and Co-workers  who first described a polymorphism involving the presence (insertion, I) or absence (deletion, D) of a 287-bp sequence of DNA in intron 16 of the gene (NCBI ref.SNP ID: rs1799752). They found that the mean ACE activity levels in DD carriers were approximately twice that found in II genotype individuals. Intermediate levels were shown in subjects with the ID genotype which pointed towards codominancy. The I/D polymorphism accounted for approximately half (47%) of the observed variance in ACE levels in this study group. Later studies showed that the involvement of the I/D polymorphism is also detected in tissue ACE levels. , Associations between the I/D polymorphism and disease are expected as evidence favors the hypothesis that functional polymorphisms, linked with the I/D polymorphism, are involved in pathophysiological conditions through the renin-angiotensin and kinin-kallikrein systems. A lot number of studies have been published investigating the association between the I/D polymorphism and numerous clinical outcomes. These investigations included not only the presence or incidence of disease, but also covered other aspects, such as symptoms and manifestations, efficacy of drugs and therapies, interaction with other genetic or environmental factors, recovery rates, disease progression, and survival. Many studies have been conducted in the last decade to study the association of migraine with ACE gene I/D polymorphism. The result of these studies have shown a lot of variation and disparity. About four studies ,, have found ACE gene DD polymorphism to be associated with Migraine with Aura whereas one study showed it be associated with Migraine without Aura. 
Till date only one study has been done from India by Joshi et al.,  who studied the role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. They found that ACE DD genotype showed significant association in migraine patients with aura (MA) but a marginal significance in female MA patients in comparison with healthy controls. They also found synergistic role of ACE (DD)*MTHFR (CT) interaction, showing a positive association in total migraine with aura patients as well as female migraine patients with aura when compared with healthy controls.
However some published studies failed to show any association between ACE gene I/D polymorphism and Migraine. ,,, In fact, one of the studies findings indicate that ACE-DD may have a slight protective effect against migraine in male patients.  A Systematic Review and Meta-Analysis by Markus Schürks et al., in 2010 concluded that the ACE II genotype is protective against both migraine with and without aura among non-Caucasian populations. There was no association among Caucasians. 
One study done in Kashmiri population did not show an association between migraine and single nucleotide polymorphisms of CACNA1A gene.  This study included a total of 25 patients of migraine, which were compared with age and sex matched 25 healthy controls. 20 of the patients (80%) were females and 5 (20%) were males. The polymorphic analysis of CACNA1A gene revealed the presence of only the wild form of the gene for the codon E993V in both case and control groups.
We conducted our study in Jammu and Kashmir, a Northern state of India. The frequency of consangious marriage is quite high in this population. Our study compared 100 migraine patients with age and sex-matched healthy 121 controls. In the previous study by Joshi et al.,  a total of 150 migraine patients, 220 non-migraine headache patients (Disease controls) and 150 age-sex matched normotensive healthy controls were enrolled. In our study out of 100 patients, 31 were Males and 69 were Females. 57 had Migraine without aura and 43 had Migraine with aura. Among the 100 cases in our study, 15 had DD, 40 had ID and 45 had II genotype while out of 121 controls, 11 had DD, 45 had ID and 65 had II genotype. In contrary to the previous study done in northern India,  we were not able to find a statistically significant association between ACE gene I/D polymorphism with migraine as compared to controls. The reason for difference in results between our study and the studies showing an association between ACE gene I/D polymorphism and migraine including the one done in India could be because of different ethnicity in study populations as several authors have suggested that the frequency I/D genotype vary according to ethnicity.  The Kashmiri population is slightly different from the rest of country in being ethnically related to Aryans. This does not mean that ACE gene does not play any role in migraine but maybe has a little role only or some other SNP is involved. So a continuous research is needed in this regard in order to find the genes and different polymorphism that increase the susceptibility of Kashmiri population to migraine.
ACE gene I/D polymorphism is not associated with migraine.
Further research is needed to determine the genetic influence on migraine.
| References|| |
World Health Organization. Atlas of Headache Disorders and Resources in the World 2011. Geneva, Switzerland: World Health Organization; 2011.
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-9.
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9.
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001;41:646-57.
Wang SJ. Epidemiology of migraine and other types of headache in Asia. Curr Neurol Neurosci Rep 2003;3:104-8.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3 rd
edition (beta version). Cephalalgia 2013;33:629-808.
Peroutka SJ. Dopamine and migraine. Neurology 1997;49:650-6.
Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 2009;9:369-79.
Kors EE, Haan J, Ferrari MD. Genetics of primary headaches. Curr Opin Neurol 1999;12:249-54.
Honkasalo ML, Kaprio J, Winter T, Heikkilä K, Sillanpää M, Koskenvuo M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 1995;35:70-8.
Riordan JF. Angiotensin-I-converting enzyme and its relatives. Genome Biol 2003;4:225.
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, et al
. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-8.
Kowa H, Fusayasu E, Ijiri T, Ishizaki K, Yasui K, Nakaso K, et al
. Association of the inser-tion/deletion polymorphism of the angiotensin I-converting en-zyme gene in patients of migraine with aura. Neurosci Lett 2005;374:129-31.
Joshi G, Pradhan S, Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J Neurol Sci 2009;277:133-7.
Horasanlı B, Ataç FB, Çöven I, Karakurum Goksel B, Benli S. Angiotensin I-converting enzyme gene (I/D) polymorphism in patients with migraine. Headache 2013;53:161-4.
Paterna S, Di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A, et al
. Angiotensin - Converting enzyme gene deletion polymorphism determines an in-crease in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000;43:133-6.
Lin JJ, Wang PJ, Chen CH, Yueh KC, Lin SZ, Harn HJ. Homozygous deletion genotype of angiotensin converting enzyme confers protection against mi-graine in man. Acta Neurol Taiwan 2005;14:120-5.
Lea RA, Ovcaric M, Sundholm J, Solyom L, MacMillan J, Grif-fiths LR. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to in-crease migraine susceptibility. Brain Res Mol Brain Res 2005;136:112-7.
Tronvik E, Stovner LJ, Bovim G, White LR, Gladwin AJ, Owen K, et al
. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol 2008;8:4.
Palmirotta R, Barbanti P, Ludovici G, De Marchis ML, Ialongo C, Egeo G, et al
. Association between migraine and ACE gene (insertion/deletion) polymorphism: The BioBIM study. Pharmacogenomics 2014;15:147-55.
Schürks M, Rist PM, Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: A systematic review and meta-analysis. Headache 2010;50:588-99.
Bashir A, Saleem S, Wani M, Rasool R, Wani IY, Gulnar A, et al
. Association of single nucleotide polymorphisms of CACNA1A gene in migraine. Indian J Hum Genet 2014;20:59-63.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]